Works by Žuran, Ivan
Results: 3
Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial).
- Published in:
- Aging Male, 2020, v. 23, n. 5, p. 1442, doi. 10.1080/13685538.2020.1793132
- By:
- Publication type:
- Article
The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
- Published in:
- Aging Male, 2018, v. 21, n. 3, p. 158, doi. 10.1080/13685538.2018.1468429
- By:
- Publication type:
- Article
The Effect of Additional Treatment with Empagliflozin or Semaglutide on Endothelial Function and Arterial Stiffness in Subjects with Type 1 Diabetes Mellitus—ENDIS Study.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 7, p. 1945, doi. 10.3390/pharmaceutics15071945
- By:
- Publication type:
- Article